Company Filing History:
Years Active: 2021-2022
Title: Rajesh Thipparaboina: Innovator in Pharmaceutical Chemistry
Introduction
Rajesh Thipparaboina is a notable inventor based in Mancherial, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative processes for drug preparation. With a total of 2 patents to his name, Thipparaboina is recognized for his expertise and dedication to advancing pharmaceutical science.
Latest Patents
Thipparaboina's latest patents include a process for the preparation of Siponimod and its various forms. This patent outlines a comprehensive method for creating crystalline polymorphic forms of Siponimod base, Siponimod hemifumarate, and other salts. It also details the preparation of solid dispersions and pharmaceutical compositions containing these compounds. Another significant patent focuses on the crystalline forms of Roxadustat, specifically Roxadustat Form-γ and Form-δ. This invention includes processes for their preparation and the development of co-crystals and pharmaceutical compositions.
Career Highlights
Rajesh Thipparaboina is currently employed at Dr. Reddy's Laboratories, Incorporated, a leading pharmaceutical company. His work at Dr. Reddy's has allowed him to collaborate on various innovative projects aimed at improving drug formulations and delivery systems. His contributions have been instrumental in enhancing the company's research and development efforts.
Collaborations
Thipparaboina has worked alongside talented colleagues such as Srinivas Oruganti and Krishnarao Chintada. Their collaborative efforts have fostered a productive environment for innovation and have led to the successful development of new pharmaceutical products.
Conclusion
Rajesh Thipparaboina is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in drug preparation processes. His patents reflect his commitment to innovation and excellence in the field. Through his contributions, he continues to impact the pharmaceutical industry positively.